News & Updates

Degarelix tied to BMD decrease in prostate cancer

07 Dec 2022

Treatment with degarelix results in a substantial reduction in bone mineral density (BMD) and an increase in bone turnover markers, reports a study.

Degarelix tied to BMD decrease in prostate cancer

07 Dec 2022

Transvaginal photobiomodulation helps resolve pelvic pain, dysuria

06 Dec 2022

Most women with interstitial cystitis/bladder pain syndrome (IC/BPS) achieve a significant reduction in pelvic pain and dysuria following transvaginal photobiomodulation (TV-PBM), previously referred as low-level laser therapy, according to real-world data.

Transvaginal photobiomodulation helps resolve pelvic pain, dysuria

06 Dec 2022

Original New Drug Application Approvals by US FDA (16 - 30 November 2022)

05 Dec 2022

New drug applications approved by US FDA as of 16 - 30 November 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 30 November 2022)

05 Dec 2022

MDT without ADT delays systemic therapy initiation in recurrent prostate cancer

21 Nov 2022 by

In patients with solitary metastatic recurrences of prostate cancer, metastasis-directed therapy (MDT without androgen deprivation therapy (ADT) can lead to delayed initiation of systemic therapy, according to a study.

MDT without ADT delays systemic therapy initiation in recurrent prostate cancer

21 Nov 2022

Vasovasostomy common in men undergoing vasectomy reversal after testosterone therapy

19 Nov 2022

Among men seeking vasectomy reversal (VR) after testosterone therapy (TT), vasovasostomy (VV) appears to be a very common procedure that is likely to succeed.

Vasovasostomy common in men undergoing vasectomy reversal after testosterone therapy

19 Nov 2022

Microscopic haematuria linked to chronic kidney disease

19 Nov 2022

Individuals with microscopic haematuria, especially persistent haematuria, appear to be at heightened risk of chronic kidney disease, as shown in a study.

Microscopic haematuria linked to chronic kidney disease

19 Nov 2022

Radiotherapy vs prostatectomy: Which is better for prostate cancer treatment?

19 Nov 2022

External beam radiation therapy with low-dose rate brachytherapy boost appears to result in worse urinary irritative/obstructive and bowel functions but better urinary incontinence function through 5 years after treatment when compared to radical prostatectomy, reports a recent study.

Radiotherapy vs prostatectomy: Which is better for prostate cancer treatment?

19 Nov 2022

Needle disinfection with povidone-iodine, formalin reduces infections after prostate biopsy

18 Nov 2022

Intrarectal povidone-iodine cleansing along with formalin disinfection of the biopsy needle tip helps reduce infectious complications following transrectal prostate biopsy, a study has shown.

Needle disinfection with povidone-iodine, formalin reduces infections after prostate biopsy

18 Nov 2022

Cell-cycle progression tied to metastasis-free survival in high-risk prostate cancer

17 Nov 2022

Cell-cycle progression, but not phosphatase and tensin homolog, appears to significantly elevate the risk of metastasis in men with prostate cancer following Cancer of the Prostate Risk Assessment Post-Surgical adjustment, suggests a study.

Cell-cycle progression tied to metastasis-free survival in high-risk prostate cancer

17 Nov 2022

Baseline penile curvature predicts improvement in Peyronie's disease treated with CCH

17 Nov 2022

In men with Peyronie’s disease (PD) treated with intralesional Collagenase Clostridium histolyticum (CCH), those with greater baseline curvature are more likely to achieve improvement, reaching up to 60 percent for patients with ≥60 degrees, a study has shown.

Baseline penile curvature predicts improvement in Peyronie's disease treated with CCH

17 Nov 2022

News & Updates

Filter by Specialty:

Specialty:

Degarelix tied to BMD decrease in prostate cancer

Degarelix tied to BMD decrease in prostate cancer

Transvaginal photobiomodulation helps resolve pelvic pain, dysuria

Transvaginal photobiomodulation helps resolve pelvic pain, dysuria

Original New Drug Application Approvals by US FDA (16 - 30 November 2022)

Original New Drug Application Approvals by US FDA (16 - 30 November 2022)

MDT without ADT delays systemic therapy initiation in recurrent prostate cancer

MDT without ADT delays systemic therapy initiation in recurrent prostate cancer

Vasovasostomy common in men undergoing vasectomy reversal after testosterone therapy

Vasovasostomy common in men undergoing vasectomy reversal after testosterone therapy

Microscopic haematuria linked to chronic kidney disease

Microscopic haematuria linked to chronic kidney disease

Radiotherapy vs prostatectomy: Which is better for prostate cancer treatment?

Radiotherapy vs prostatectomy: Which is better for prostate cancer treatment?

Needle disinfection with povidone-iodine, formalin reduces infections after prostate biopsy

Needle disinfection with povidone-iodine, formalin reduces infections after prostate biopsy

Cell-cycle progression tied to metastasis-free survival in high-risk prostate cancer

Cell-cycle progression tied to metastasis-free survival in high-risk prostate cancer

Baseline penile curvature predicts improvement in Peyronie's disease treated with CCH

Baseline penile curvature predicts improvement in Peyronie's disease treated with CCH